NIA hosts its second 2017 webinar that focuses on current regulatory priorities and activities open for member feedback at national and international level.

The first 2017 webinar in February saw Regulatory Affairs Director David Carlander discuss with members around topics including the nanoform testing and national directories.  On May 24, the webinar will discuss all currently relevant topics, including REACH annex modification and nanomaterial definitions.  Members will be notified of initial agenda in May and can nominate topics of importance for inclusion.

NIA and EuropaBio are pleased to host a joint webinar that present the opportunities and development pathways within nanomedicine.

Members from both networks will come together to understand how nanomaterials play a role across healthcare biotechnology applications, with examples of nanomedicines in development and clinical application.  The webinar will also explore when regulatory worlds come together with healthcare and nano, and highlight funding opportunities for organisations to work together in developing novel nanomedicines.

A number of H2020 funded projects are working on various aspects of the Safe-by-Design (SbD) concept and all rely upon industry to understand its meaning and how to use the tools being developed in these projects. Disseminating this knowledge to a wider audience will help in the acceptance and uptake of SbD by companies and will also allow the projects to learn more about stakeholder needs.

Building on the success of the 2015 symposium held at Legend Safari Lodge, Limpopo Province, South Africa, this conference will also bring together a multidisciplinary cross section of delegates from different scientific areas specializing in all aspects of nanosafety.